sphygmomanometer, 8 was 120 mm Hg in the right hand and 110 mm Hg in the left hand. Her left arm circumference at 5 cm below the elbow was 29.4 cm, which exceeded that of the unaffected right arm by 4.2 cm (►Table 1). We examined the edema further in suspicion of RAassociated secondary lymphedema.
Diagnosis and Compression Therapy
Segmental body water volume measurement by bioelectrical impedance analysis was according to a published method 9 that revealed arm body water volume (ABW) of 2,050 mL in the left arm which exceeded that in the right arm by 710 mL (►Table 1).
99m
Tc-human serum albumin lymphoscintigraphy Attempts at full-scale compression therapy were unsuccessful since she could not put on the necessary medium-pressure compression sleeve (pressure: 20-25 mm Hg) 11 due to poor grip and impaired finger dexterity. Switching to a low-pressure compression sleeve (14-18 mm Hg) did not improve the edema. She underwent LVA 3 months after the first visit.
LVA Procedure
According to indocyanine green lymphography (ICG-LG) at the time of operation, a diffuse pattern 12 spread from the hand to the forearm consistently with the extent of the edema and a linear pattern starting around the cubital fossa vanished proximal to the medial epicondyle of the humerus (►Fig. 3A, B). These findings indicated that the lymphatic flow became congested from the hand to the forearm, with normally functioning superficial lymphatic vessels around the cubital fossa. We located the functioning lympathic vessels at the cubital fossa as indicated by ICG-LG and created two lymphaticovenular anastomoses, both in a side-to-end fashion, using a surgical microscope under general anesthesia (►Fig. 3C, D). Degeneration of the anastomosed lymphatic vessels was considered mild and classified as ectasis type by NECST classification. 13 We could not confirm any obvious lymphatic vessel obstruction during surgery.
Postoperative Course
The patient resumed wearing a low-pressure sleeve after surgery. Her edema improved rapidly following LVA (►Fig. 1C, D), and arm circumference at 5 cm below the elbow had reduced by 5.4 cm at 20 months postoperatively (►Table 1). With a left-arm ABW decrease from 2,050 to 1,250 mL, the resulting difference between arms decreased from 710 to 90 mL (►Fig. 4). The reduction rate of edema, calculated as: (1-[difference in ABW between arms after LVA/difference in ABW between arms before LVA]) Â 100%, was remarkable at 87.3%. She was able to maintain the decreased arm circumference and ABW with the low-pressure compression sleeve, although the edema relapsed without the garment.
Discussion
Extremity edema associated with RA was first pointed out as a kind of lymphedema in 1968 4 and later became known as RL. Several hypotheses have been suggested on the etiology of RL to date, including lymphangitis, lymphatic obstruction caused by fibrin, capillary permeability increase, abnormal fibrinolysis, and possible fibrosis of the superficial lymph vessels. 6 Bursitis and subsequent pressure elevation in the bursa have also been proposed to cause lymphedema in patients with RA.
14 In the present case, bone destruction of the elbow joint and localized edema distal to the elbow were observed only in the left arm and the degenerative change in the lymphatic vessels at the LVA site was mild.
Judging from these findings and despite the absence of a clear obstruction intraoperatively, we presumed that the patient's RL arose secondarily from lymphatic obstruction by the deformed left elbow joint or by fibrin plugs at the left elbow. Since no edema was observed in the right arm or either leg, we considered systemic inflammation as a primary pathological change of RA to cause lymphedema to be unlikely. According to past reports, RL occurs more frequently in the upper limbs, especially in the hands, and sometimes bilaterally.
6,7,15 RL may be an initial symptom of RA. 15 As RL does not show any consistent relationship with the duration or severity of arthritis, it is often difficult to improve RL using conventional antirheumatic drugs, such as DMARDs, corticosteroids, or methotrexate, 7 which necessitates other therapies for edema relief. Among drug treatments, etanercept 6 and a kind of CAM 7 (Juzentaihoto/TJ-48) were reported to improve RL for some patients. Otherwise, the cornerstone of RL management is compression therapy 6 as in the case of secondary lymphedema from other causes.
2
Compression therapy for RL has a characteristic problem different from other forms of lymphedema in that arm dysfunction caused by the primary disease, such as RA in this case, renders it difficult for the patient to wear compression garments. In general, compression sleeves with medium pressure or more (i.e., above 20 mm Hg) are required for arm lymphedema with shape distortion as in this patient, 11 although many RA patients cannot put on the sleeve by themselves due to poor grip strength and impaired finger dexterity. We typically perform LVA on lymphedema patients after at least 3 months of wearing a compression garment with medium pressure or more 9 based on the notion that sufficient LVA gains cannot be achieved without adequate compression, even after the surgery, in agreement with other authors. 16, 17 Here, we prescribed a low-pressure sleeve at the first visit in view of the patient's diminished hand function, which was ultimately ineffective. Wearing the same sleeve postoperatively, however, the girth and ABW of the affected arm became sustainably decreased. We consider that the edema was controlled not only by LVA but also by the low-pressure sleeve because it relapsed without the sleeve after LVA. The present case suggests that even RL patients who have difficulty wearing a medium-pressure sleeve due to hand dysfunction can achieve good results with a low-pressure sleeve if preceded by LVA. Especially for RL in long-term RA patients with diminished hand function, LVA ahead of full-scale compression therapy may be considered. There are several limitations to this report. First, we could not identify the precise cause of the patient's RL. Second, it was not possible to conclude whether LVA followed by compression therapy with a low-pressure garment could work for all RL patients based on this single case. Further prospective studies of larger cohorts are needed to confirm the efficacy of LVA for RL.
Conclusion
LVA represents an effective treatment option for remaining RL in RA treatment. Particularly in patients who have difficulty with full-scale compression therapy due to hand function limitations, LVA in concert with a low-pressure compression garment may reduce RL and help edema management without concern for hand dysfunction.
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